SLC25A51 is a mammalian mitochondrial NAD+ transporter
- Nature. 2020 Dec;588(7836):174-179. doi: 10.1038/s41586-020-2741-7.
- 1. Department of Physiology and Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- 2. Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA.
- 3. Department of Biomedicine, University of Bergen, Bergen, Norway.
- 4. Department of Chemical Biology, Max Planck Institute for Medical Research, Heidelberg, Germany.
- 5. Faculty of Chemistry and Earth Sciences, University of Heidelberg, Heidelberg, Germany.
- 6. Lewis-Sigler Institute for Integrative Genomics, Department of Chemistry, Princeton University, Princeton, NJ, USA.
- 7. Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
- 8. Department of Pathology and Laboratory Medicine, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- 9. Institute of Chemical Sciences and Engineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
- 10. Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA. [email protected].
- 11. Department of Physiology and Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. [email protected].
Mitochondria require nicotinamide adenine dinucleotide (NAD+) to carry out the fundamental processes that fuel respiration and mediate cellular energy transduction. Mitochondrial NAD+ transporters have been identified in yeast and Plants1,2, but their existence in mammals remains controversial3-5. Here we demonstrate that mammalian mitochondria can take up intact NAD+, and identify SLC25A51 (also known as MCART1)-an essential6,7 mitochondrial protein of previously unknown function-as a mammalian mitochondrial NAD+ transporter. Loss of SLC25A51 decreases mitochondrial-but not whole-cell-NAD+ content, impairs mitochondrial respiration, and blocks the uptake of NAD+ into isolated mitochondria. Conversely, overexpression of SLC25A51 or SLC25A52 (a nearly identical paralogue of SLC25A51) increases mitochondrial NAD+ levels and restores NAD+ uptake into yeast mitochondria lacking endogenous NAD+ transporters. Together, these findings identify SLC25A51 as a mammalian transporter capable of importing NAD+ into mitochondria.